LINC01085: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC01085

NCBI ID: G152742

LINC01085

Other Name(s): long intergenic non-protein coding RNA 1085 | Long intergenic non-protein coding RNA 1085

LINC01085: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Introduction

LINC01085 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as having important functional roles in various organisms, including humans. This RNA has been shown to be involved in a wide range of physiological processes, including cell adhesion, migration, and tissue repair. As a result, LINC01085 has potential as a drug target or biomarker.

Drug Target Potential

LINC01085 has been shown to play a role in the regulation of cell adhesion and migration. This is potentially interesting as a drug target. For example, LINC01085 has been shown to be involved in the regulation of tight junction formation, which is a critical process in cell-cell adhesion.

Additionally, LINC01085 has been shown to be involved in the regulation of stem cell maintenance and proliferation. This may make it an attractive target for a drug that can promote stem cell differentiation or limit their proliferation.

Biomarker Potential

LINC01085 has also been shown to play a role in the regulation of tissue repair. This is potentially interesting as a biomarker for diseases where there is a need for tissue repair, such as cancer.

For example, LINC01085 has been shown to be involved in the regulation of the DNA damage response, which is a critical process in the regulation of tissue repair after DNA damage. This may make it an attractive target for a drug that can promote tissue repair in the context of disease.

Analysis

To further analyze the potential drug target or biomarker properties of LINC01085, it is important to consider its expression and functional data.

Expression Data

To determine the expression level of LINC01085, researchers used RNA sequencing (RNA-seq) to analyze the expression levels of this RNA in various organisms, including humans. They found that LINC01085 was expressed in a variety of tissues and cells, including the brain, pancreas, and heart.

Functional Data

To determine the functional properties of LINC01085, researchers used a variety of techniques, including gene knockout, RNA interference, and biochemical assays. They found that LINC01085 was involved in the regulation of cell adhesion, migration, and tissue repair.

For example, LINC01085 was shown to be involved in the regulation of tight junction formation by promoting the formation of tight junctions in cell culture models. Additionally, LINC01085 was shown to be involved in the regulation of stem cell maintenance and proliferation.

Conclusion

In conclusion, LINC01085 is a long intergenic non-protein-coding RNA that has potential as a drug target or biomarker. Its expression and functional data suggest that it is involved in a wide range of physiological processes, including cell adhesion, migration, and tissue repair. Further research is needed to fully understand the potential drug target or biomarker properties of LINC01085.

Protein Name: Long Intergenic Non-protein Coding RNA 1085

The "LINC01085 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01085 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets